LB 337, supported by Bio Nebraska, will reform the insurance industry practice of ‘step therapy’ to give patients and doctors the power to determine the best treatment plan. Read more
Adjuvance Technologies, a member of Bio Nebraska, aims to be a part of the second generation of COVID-19 vaccines. Reported by Lincoln’s KLKN-TV. Read more
Bio Nebraska members Grail, Amgen, and Bristol Myers Squibb are included in a collaboration to evaluate cancer early detection technology for minimal residual disease. Read more
MatMaCorp a member of Bio Nebraska, announced that the U.S. FDA has granted Emergency Use Authorization of MatMaCorp’s COVID-19 2SF RNA test for the detection of SARS-CoV-2 on the company’s Solas 8® portable detection system. Read more
ADS Biotec, a member of Bio Nebraska, announced the European launch and immediate availability of its COVID-19 Rapid Antigen Test. Read more
Brand Institute, PSC Biotech, and the Biotechnology Innovation Organization (BIO) have partnered to provide a Webinar Series on “The Art and Science of Naming Drugs and Medical Devices.” Read more
Rakuten Medical announced today it has acquired phthalocyanine dyes, including IRDye® 700DX, from LI-COR Biosciences, a member of Bio Nebraska. Read more
Bio Nebraska talked to CRB for our first Member Spotlight of the new year. Read more
Lincoln Journal Star’s Matt Olberding reports on the renewable energy contract between Monolith Materials and Nebraska Public Power District, a member of Bio Nebraska. Read more
